Anemia in cancer.

@article{Dicato2010AnemiaIC,
  title={Anemia in cancer.},
  author={Mario A. Dicato and Laurent Plawny and Marc Diederich},
  journal={Annals of oncology : official journal of the European Society for Medical Oncology},
  year={2010},
  volume={21 Suppl 7},
  pages={
          vii167-72
        }
}
Inflammatory cytokines such as tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6), among others, play a major role in the pathophysiology of anemia in the cancer patient not only through complex mechanisms of the purely inflammatory situation but also through genetic regulatory aspects of erythropoiesis via GATA-1 and GATA-2, and other factors. In terms of therapy, iron is used more and more; the late side effects of transfusions are not really understood and the recent controversy… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 45 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 51 REFERENCES

Erythropoiesis-stimulating agents in cancer patients: ESMO recommendations for use.

  • Annals of oncology : official journal of the European Society for Medical Oncology
  • 2009
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL

Benefits and harms of erythropoiesis-stimulating agents for anemia related to cancer: a meta-analysis.

  • CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
  • 2009